Revenues of USD 1,028m (+3% vs. ARCe, +2% vs. cons)EBITDA of USD 397m (+11% vs. ARCe, +12% vs. cons)Cash flow above as wellWe anticipate a narrower guidance range for 2025...... With a potential modest upward revision to the midpoint of EBITDAPositive report - expect the share to trade in line with peers tomorrow given the recent strenght
